Clinical Use of Radiopharmaceuticals in Boron Neutron Capture Therapy
- PMID: 35607631
- PMCID: PMC9123127
- DOI: 10.1007/s13139-022-00739-5
Clinical Use of Radiopharmaceuticals in Boron Neutron Capture Therapy
Conflict of interest statement
Conflict of InterestYun-Sang Lee and Hyo Jung Seo declare no competing interests.
Similar articles
-
Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.Bioorg Med Chem. 2010 May 1;18(9):3059-65. doi: 10.1016/j.bmc.2010.03.050. Epub 2010 Mar 27. Bioorg Med Chem. 2010. PMID: 20371186
-
Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals.Cancer Biother Radiopharm. 2022 Jun;37(5):342-354. doi: 10.1089/cbr.2021.0276. Epub 2022 Apr 13. Cancer Biother Radiopharm. 2022. PMID: 35426728 Review.
-
Neutron capture autoradiographic study of the biodistribution of 10B in tumor-bearing mice.Appl Radiat Isot. 2004 Oct;61(4):585-90. doi: 10.1016/j.apradiso.2004.03.084. Appl Radiat Isot. 2004. PMID: 15246403
-
Boron neutron capture therapy for urological cancers.Int J Urol. 2022 Jul;29(7):610-616. doi: 10.1111/iju.14855. Epub 2022 Mar 3. Int J Urol. 2022. PMID: 35240726 Review.
-
A new approach for the synthesis of isonitrile carborane derivatives. Ligands for metal based boron neutron capture therapy (BNCT) and boron neutron capture synovectomy (BNCS) agents.J Inorg Biochem. 2001 May;85(1):43-51. doi: 10.1016/s0162-0134(00)00222-1. J Inorg Biochem. 2001. PMID: 11377694
References
-
- Sauerwein W, Wittig A, Moss R, Nakagawa Y. Neutron capture therapy; principles and application. Springer:Verlag Berlin, Heidelberg; 2012.
-
- Locher GL. Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol. 1936;36:1–13.
Publication types
LinkOut - more resources
Full Text Sources